Announced Fri, 16 Oct, 2026 · 19:32 IST

Eiko LifeSciences allots shares on warrant conversion to promoter

Warrants ConvertedFund Raising View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+5.6%Reaction day
₹49.00
prior close
—
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-1.7%+7.3% vs market
Specialty Chemicals peers, median of 101sector-1.8%+7.4% vs sector

On the reaction day the stock moved 7.3 pts more than Nifty Microcap 250 and 7.4 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+5.6-1.7+7.3-1.8+7.4
Next day
+2.0-4.2+6.3-4.9+6.9
2d
+2.0-5.2+7.3-5.7+7.8
3d
+4.1-7.4+11.5-9.0+13.1
4d
+5.9-7.0+12.9-9.0+14.8
5d
+4.8-5.5+10.2-7.2+11.9
1w
—————
15d
—————
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 101Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board approved allotment of 1,50,000 equity shares on conversion of equal number of warrants at Rs. 55 each (including Rs. 45 premium) to promoter group entity Lenus Finvest Private Limited on preferential basis. Company received Rs. 61.87 lakh as balance 75 percent of the issue price. Post-allotment, Lenus Finvest holding rises from 17.34 percent to 18.18 percent. Paid-up equity capital increases to Rs. 14.80 crore (1,48,00,854 shares). All warrants held by Lenus Finvest now fully converted; 24,95,000 warrants remain pending conversion by other allottees.

Likely market impact

Slight promoter shareholding increase, minor dilution for existing shareholders, no fresh fundraising as conversion was already committed.